A Legal Firm’s View Of Investor Opportunities
Tapping Into Disruptive Medtech Trends
CMS patent attorneys Jane Hollywood and Rob Stephen say COVID-19 has not dented the enthusiasm of medtech start-up entrepreneurs from pushing back the technology boundaries in patient care delivery – in fact, they are getting younger.
You may also be interested in...
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.